New Pact Expands Oncimmune Lung Cancer Test in Spain

Jul 15, 2019

|

NEW YORK — UK immunodiagnostics firm Oncimmune said today that a distribution partner for its EarlyCDT Lung cancer assay has signed a sales and marketing agreement for the test with Spanish private healthcare organization Vithas Group.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

New Pact Expands Oncimmune Lung Cancer Test in Spain

To read the full story....

Breaking News

FDA Issues EUA to Adaptive Biotechnologies Test for T-Cell Response to COVID-19

Cue Health Over-the-Counter COVID-19 Test Gets FDA Emergency Use Authorization

German Stores to Begin Selling COVID-19 Rapid Antigen Tests for Home Use

Abbott Gets FDA EUA for Test That Detects Coronavirus, Three Other Respiratory Infections

Illumina Receives Medical Device Registration in Russia for NextSeq 550 Dx Sequencer, Reagents

DermTech Q4 Revenues Up 31 Percent

What's Popular?

C2i Genomics Acquires Sequencing Lab QNA Dx

Agilent Charges Into Liquid Biopsy Space with Resolution Biosciences Acquisition

Bio-Techne to Acquire Molecular Diagnostics Firm Asuragen for up to $320M

FDA Expands Approval of Pfizer's Lorbrena to First-Line ALK-Positive NSCLC; Approves Roche CDx

Agilent Technologies to Acquire Liquid Biopsy Firm Resolution Bioscience for up to $695M

Sponsorships